Celltrion Pharm Inc.

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

South Korea’s Hyundai Motor Group, which owns Hyundai Motor Co. and Kia Corp., has carried out a year-end mid-tier executive reshuffle marked ...

SK Inc., the investment arm of South Korea’s second-largest conglomerate SK Group, is taking preemptive steps to expand its eco-friendly busin...

Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...

SK Inc., the investment arm of South Korea’s second-largest conglomerate SK Group, is ramping up its value chain of third-generation semicondu...

South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...

South Korean companies are at risk of credit rating downgrades as the fallout of a debt default by the domestic developer of a Legoland theme park r...

South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...

South Korean companies, led by the country’s most valuable firm Samsung Electronics Co., have rushed to accumulate cash as interest rates kept...

Foreign private equity firms have taken advantage of the strong dollar to dominate corporate acquisition deals in South Korea, adding to expectation...

Rising interest rates amid a slowing global economy rattled South Korean companies’ market capitalization rankings, bumping online players suc...

The firm dollar is causing South Korean companies to postpone or cancel their plans to buy overseas firms for future growth as the US currency&rsquo...

Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...

Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...

Samsung Electronics Co. and other major South Korean companies have reduced their plant operations and capital expenditures as weakening demand amid...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...

South Korean companies scrambled for lowering debts and borrowing costs with new financial and business strategies as interest rates on corporate lo...

South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...

South Korea’s major industries, especially the petrochemical and auto parts sectors, are suffering from surging global commodity prices, a wea...

SK Group, South Korea’s No. 2 conglomerate, joined hands with TerraPower, an advanced nuclear power venture founded by billionaire Bill Gates,...

South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...

SK Group, South Korea’s third-largest conglomerate, has geared up its electric vehicle chip business development with the acquisition of a loc...

CJ Corp. launched an artificial intelligence center Wednesday, which it hopes will lead the conglomerate's digital innovation. The new CJ AI Cente...

US hedge fund Dalton Investments LLC has urged SK Inc., the holding company of South Korea’s SK Group, to focus more on share buybacks and can...

South Korea’s major companies are in a sticky situation over their businesses in Russia following its invasion of Ukraine. Governments in the ...

South Korean companies had dreamed of a post-COVID-19 earnings recovery as the globe geared up for economic reopening. But their hopes are now dampe...

South Korean companies are revising their business plans for this year as soaring oil prices slam Asia’s fourth-largest economy. Inflation is ...